c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a...

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Hypoxia-inducible factor-1alpha (HIF-1alpha) is a key regulator of cellular response to hypoxia and a validated drug target.
• Existing research focuses on inhibiting HIF-1alpha expression or transcriptional activity.
• However, the complete regulatory network of HIF-1alpha remains incompletely understood.

Purpose of the Study:

• To elucidate novel regulatory mechanisms governing HIF-1alpha stability and function.
• To investigate the potential role of c-Jun in modulating HIF-1alpha activity.
• To explore the implications of this interaction in cancer progression.

Main Methods:

• Co-immunoprecipitation assays to confirm protein-protein interactions.
• Western blotting to assess protein levels and degradation.
• Analysis of HIF-1alpha target gene expression.
• Site-directed mutagenesis to identify critical domains and phosphorylation sites.

Main Results:

• c-Jun directly associates with the oxygen-dependent degradation domain of HIF-1alpha.
• This interaction inhibits ubiquitination and subsequent proteasomal degradation of HIF-1alpha.
• Stabilization of HIF-1alpha by c-Jun enhances its target gene transcription and promotes angiogenesis.
• c-Jun's DNA-binding and heterodimerization domains are crucial, while Ser(63/73) phosphorylation is not required for this regulatory function.

Conclusions:

• c-Jun possesses a previously unrecognized, non-transcriptional function in stabilizing HIF-1alpha.
• This interaction represents a distinct regulatory pathway for HIF-1alpha activity.
• The findings provide significant mechanistic insights into tumor progression involving both c-Jun and HIF-1alpha.